BIOTechNZ
  • ABOUT
    • OUR EXECUTIVE COUNCIL
    • OUR MEMBERS
    • OUR PARTNERSHIPS & AFFILIATES
    • JOIN US TODAY
    • REPORTS
  • News
    • SUBSCRIBE
  • EVENTS
    • Life Sciences Summit
  • MEMBERS
  • RESOURCES
    • Submissions
  • JOIN
  • CONTACT

The Only Constant in Life is Change

29 May 2025

Our new Executive Council has been focused on enhancing member value, ensuring you receive maximum benefit from your membership while we deliver what matters most to you.

Read More

Final countdown to the Life Sciences Summit!

18 March 2025

In this issue Insights from our Executive Director Reflecting on our journey from 2017—when NZBIO faced financial challenges and joined the NZTech Group—to today is truly remarkable. Four years of … Continue reading "The precautionary principle"

Read More

Action-packed updates 

12 February 2025

In this issue Insights from our Executive Director As we kick off the year, BioTechNZ is already moving full speed ahead with exciting developments in the biotech sector.  There is … Continue reading "The precautionary principle"

Read More

Celebrating our year in biotech

16 December 2024

It has been a landmark year for BioTechNZ and our members. Let's take a moment to reflect on the progress and achievements of 2024!

Read More

Endless possibilities…

30 September 2024

Kia ora, In this issue Insights from our Executive Director  The more I work in this role the more excited I am about the convergence of once-siloed technologies across multidisciplinary … Continue reading "The precautionary principle"

Read More

Spring into innovation | September 2024 News

03 September 2024

In this issue Insights from our Executive Director  During the last month there has been plenty of discussion in the media regarding gene technologies – should our companies and researchers … Continue reading "The precautionary principle"

Read More

Life Sciences Summit Returns for 2025!

02 September 2024

We can’t wait to reconnect at Aotearoa New Zealand’s 2025 Life Science Summit – Uniting biology and technology to unleash potential. 18-19 March, 2025 at Tākina Wellington Convention and Exhibition Centre. Click here … Continue reading "The precautionary principle"

Read More

Gene tech, tools and innovation | June 2024 News

21 June 2024

It has been another busy month for biotech. More than 35 Kiwis travelled to the BIO International Convention in San Diego.

Read More

BioTechNZ News: The final countdown!

06 March 2024

In this issue Insights from our Executive Director  This year feels like it’s going to be a fast game, but a good game for the biotech sector! I am incredibly … Continue reading "The precautionary principle"

Read More
Categories
  • BIOTechNZ News
  • Events
  • Industry News
  • Industry News
  • Media Release
  • Media Release
  • Member Profiles
  • Newsletter
  • Research and Trends
Topics
  • Alternative proteins
  • Animal Biotechnology
  • Biomedicals
  • Environmental and Industrial Biotech
  • Funding
  • Future of foods
  • Gene drive technology
  • Human diagnostics & therapeutics
  • IP and Regulatory
  • MedCan
  • Media Release
  • newsletter

BIOTechNZ News

The precautionary principle

The Precautionary Principle, there are many definitions, but the most common expression today claims that a practice, substance or technology must be banned or prohibited if it cannot be proven (with certainty) to be safe. Rather than trying to reduce exposure to risks or solve problems with innova

July 3, 2020

BIOTechNZ News

Congratulations to our dames and knights and our ongoing fight

Congratulations to our Neonatal expert Professor Jane Harding as she is now one of the Dame Companions of the New Zealand Order of Merit (NZOM). Congratulations also to medical researcher Professor Robert Elliott who has been appointed Knight Companions of the NZOM. Well deserved recog

June 3, 2020

Media Release

New Zealand biotech firm tackling COVID-19 and M. bovis

Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis. Pictor has received a grant of $500,000 from the $25 million MBIE COVID-19 Innovation Acceleration Fund,

May 18, 2020

Media Release

Initial funding opens doors for national vaccine strategy

New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.

May 8, 2020

BIOTechNZ News

COVID-19: The massive social and economic experiment

Currently, an estimated 2.6 billion people – one-third of the world’s population – are living under some kind of lockdown or quarantine. This is arguably the largest social and economic experiment ever conducted. There are lots of coronavirus memes on the internet, however,&

May 6, 2020

Industry News

Top scientists call for urgent COVID vaccine strategy to ensure New Zealand’s health and economic viability

Some of New Zealand’s top scientists are urging the need for a national COVID-19 vaccine programme to ensure New Zealand is best placed to access an effective vaccine at the earliest opportunity. Malaghan Institute Director Professor Graham Le Gros and University of Otago’s Professor Miguel

April 15, 2020

BIOTechNZ News

Stay home. It WILL save lives

Hi, We’re facing new and fast-moving challenges and opportunities. For most of you this will mean your day to day work will continue, albeit in very different working environments. A significant number of our biotech companies are defined as essential services. If you believe yo

April 2, 2020

BIOTechNZ News

Major medicinal cannabis summit postponed

“We have made the difficult decision to postpone the MedCan Summit 2020 this week. However, we remain firmly committed to hosting New Zealand’s first medicinal cannabis summit later this year, as the future of large events and international travel becomes clear,” says Dr Zahra Champion, Execu

March 17, 2020

BIOTechNZ News

Biotechnology leading the charge to develop a COVID-19 vaccine for the world

The impact of coronavirus will be far reaching, from increasing reports of the number of infections to the world’s biggest companies painting a bleak picture of broken supply chains, disrupted manufacturing, empty stores and flagging demand for their wares. It is now down to the scientist

March 4, 2020

Previous 1 … 11 12 13 … 24 Next

New Zealand Tech Alliance Member

 

©2020 BioTech New Zealand Association

 

  • About us
  • Our team
  • Our members
  • Privacy policy
  • Terms of use
  • Contact us
  • Subscribe for updates
  • Become a member
  • Latest news
  • Upcoming events

Email: info@biotechnz.org.nz

Phone: +64 9 300 7559